Literature DB >> 7852350

Molecular requirements for the interaction of class II major histocompatibility complex molecules and invariant chain with calnexin.

B Arunachalam1, P Cresswell.   

Abstract

Molecular chaperones are believed to retain misfolded and incompletely assembled oligomeric proteins in the endoplasmic reticulum (ER). Here, we have further analyzed the association of one such chaperone, calnexin, with human major histocompatibility complex class II alpha and beta subunits and the invariant chain. Calnexin associates with transport-competent invariant chain trimers (p33 or p41), as well as ER-retained trimers (p35/33 or p43/41), suggesting that ER retention of the latter is not because of calnexin association. Neither the replacement of the transmembrane segment of the DR beta subunit with a glycosyl phosphatidylinositol anchor nor deglycosylation of any of these proteins with tunicamycin or endoglycosidase H treatment abolished calnexin association. Using a cell-permeabilization system, we were unable to observe association of newly synthesized glycopeptides with calnexin, arguing that calnexin may not act like a simple lectin for association with glycoproteins. The results indicate that neither transmembrane regions nor N-linked glycans are exclusively responsible for calnexin association. Based on our data and the observations of others, we suggest that these features may have varying significance for different glycoproteins in determining their interaction with calnexin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852350     DOI: 10.1074/jbc.270.6.2784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Quality control of transmembrane domain assembly in the tetraspanin CD82.

Authors:  K S Cannon; P Cresswell
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  The solution NMR structure of glucosylated N-glycans involved in the early stages of glycoprotein biosynthesis and folding.

Authors:  A J Petrescu; T D Butters; G Reinkensmeier; S Petrescu; F M Platt; R A Dwek; M R Wormald
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin.

Authors:  I Wada; M Kai; S Imai; F Sakane; H Kanoh
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

4.  Contributions of the Lectin and Polypeptide Binding Sites of Calreticulin to Its Chaperone Functions in Vitro and in Cells.

Authors:  Ronnie Lum; Samar Ahmad; Seo Jung Hong; Daniel C Chapman; Guennadi Kozlov; David B Williams
Journal:  J Biol Chem       Date:  2016-07-13       Impact factor: 5.157

5.  N-linked glycosylation is required for nicotinic receptor assembly but not for subunit associations with calnexin.

Authors:  Christian P Wanamaker; William N Green
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

6.  Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins.

Authors:  J R Peterson; A Ora; P N Van; A Helenius
Journal:  Mol Biol Cell       Date:  1995-09       Impact factor: 4.138

7.  Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport.

Authors:  J D Mijnes; L M van der Horst; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin.

Authors:  J D Oliver; H L Roderick; D H Llewellyn; S High
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

9.  Calnexin is involved in apoptosis induced by endoplasmic reticulum stress in the fission yeast.

Authors:  Renée Guérin; Geneviève Arseneault; Stéphane Dumont; Luis A Rokeach
Journal:  Mol Biol Cell       Date:  2008-08-13       Impact factor: 4.138

10.  Calnexin regulates apoptosis induced by inositol starvation in fission yeast.

Authors:  Renée Guérin; Pascale B Beauregard; Alexandre Leroux; Luis A Rokeach
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.